MedPath

Helmet Ventilation in Acute Hypercapnic Respiratory Failure

Phase 4
Completed
Conditions
Hypercapnic Respiratory Failure
Chronic Obstructive Pulmonary Disease
Interventions
Device: Helmet (Starmed)
Device: Total Face mask (Respironics)
Registration Number
NCT01645358
Lead Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Brief Summary

Lack of tolerance to the treatment, makes the interface choice for non-invasive ventilation (NIV) one of the key factor. To date the helmet is rarely used in Acute Hypercapnic Respiratory Failure (AHRF), because of its large dead space, despite in hypoxic respiratory failure, it is largely employed as a "rotating" strategy when the facial mask is poorly tolerated.

In a multicenter randomized controlled trial, the investigators will compare the clinical efficacy of a new helmet designed to specifically improve the performance in chronic obstructive pulmonary disease (COPD) versus a full face mask during an episode of AHRF.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • pH < 7,35 and PaCO2 > 45 mmHg
  • respiratory rate > 20 b/min
Exclusion Criteria
  • hypoxic respiratory failure
  • coma
  • inability to stand NIV
  • lack of informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Helmet to deliver NIVHelmet (Starmed)-
Total Face to deliver NIVTotal Face mask (Respironics)-
Primary Outcome Measures
NameTimeMethod
Arterial Blood gasesat 1 hour after the start of NIV
Secondary Outcome Measures
NameTimeMethod
Arterial Blood GasesOnce a day at 8 am until discharge

Trial Locations

Locations (2)

Sant'Orsola malpighi Hospital

🇮🇹

Bologna, Italy

Sant'Orsola Malpighi

🇮🇹

Bologna, Italy

© Copyright 2025. All Rights Reserved by MedPath